Showing results (231-240 of 304) with videos related to

Sort By:
Pageof 31
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancerC Bokemeyer, J Beyer, B Metzner, et al.
Cancer Gene Therapy|January 1, 1997
Differential transfection efficiency rates of the GM-CSF gene into human renal cell carcinoma lines by lipofectionA Hernández, K Zöller, J Enczmann, et al.
Molecular and Cellular Biology|September 1, 1996
The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a potential actin binding domain and interacts with calmodulin and Rho family GTPasesS Brill, S Li, C W Lyman, et al.
Deutsche Medizinische Wochenschrift (1946)|January 24, 1992
[The long-term toxicity of polychemotherapy in successfully treated testicular carcinoma]H R Schwabe, R Herrmann, M Mathew, et al.
British Journal of Cancer|May 20, 2004
Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG)J Classen, H Schmidberger, C Meisner, et al.
Der Urologe. Ausg. A|March 1, 1987
[Venous insufficiency of the corpora cavernosa as (additional) cause of erectile dysfunction]C G Stief, W F Thon, H Gall, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|August 1, 1993
[A study of the quantitative dual-parameter flow cytometry analyses of cellular antigens on transitional cells for the diagnosis of bladder cancer]T Shibayama, K Decken, M Severin, et al.
Urologia Internationalis|January 1, 1995
Dual-parameter immunoflow cytometry--a new technique in the noninvasive diagnosis of bladder cancerF Jankevicius, T Shibayama, K Decken, et al.
Der Urologe. Ausg. A|April 8, 2010
[Role of immunocytology in the evaluation of patients with painless gross hematuria]B J Schmitz-Dräger, L-A Tirsar, C Schmitz-Dräger, et al.
The Journal of Urology|January 1, 1996
Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gammaG Gastl, T Ebert, C L Finstad, et al.
Pageof 31